P
roper heart valve function relies on highly organized extracellular matrix (ECM) consisting of layers rich in fibrillar collagens, glycosaminoglycans, and elastin. 1 Pathological myxomatous valves display disrupted ECM, characterized by thickening of leaflets with glycosaminoglycan accumulation, along with disorganization and excessive deposition of collagen fibers, resulting in impaired valve closure and valve regurgitation. 2 Valve leaflets are populated with valve interstitial cells (VICs) that produce ECM and mediate ECM remodeling during development or disease. Hematopoietic-derived cells have been detected in heart valves and are proposed to have synthetic properties of VICs, such as producing collagen type 1a1. 3, 4 More recently, increased inflammatory cells composed of macrophages and T cells have been described in human myxomatous mitral valves (MMVs). 2, 5 Likewise, cytokines, chemokines, and chemokine receptors are upregulated in human diseased leaflets, 5 indicative of immune cell infiltration in human myxomatous valves. Macrophage numbers are also increased in the filamin A-deficient murine model of myxomatous valve disease (MVD). 6 Moreover, we recently described that inflammation precedes pathogenic ECM remodeling in Axin2 KO (knockout) mice, another murine model of MVD. 7 Yet, immune cell contributions to heart valve development and MVD are not well characterized.
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In cardiovascular development and disease, bone marrowderived and tissue-resident immune cells are present in normal hearts and increase with disease or after injury. 8, 9 Although roles of macrophages in cardiac regeneration and myocardial fibrosis have been extensively studied, 10, 11 much less is known about macrophage lineages in heart valve development, remodeling, or homeostasis. Macrophage subtypes are involved in development and exert important homeostatic activity in numerous organ systems. 12 They also play key roles in tissue repair after injury. For instance, macrophages affect fibroblasts through paracrine activity, playing a crucial role in ECM remodeling during development, 13 while aberrant response to inflammation promotes excessive ECM deposition during fibrosis. 14 Recent studies have indicated that macrophages are more heterogeneous than assumed previously, and different subsets achieve distinct functions, which can be detrimental or beneficial to pathogenesis. 14 In the murine aorta, macrophages are present in the adventitia, and myeloid cells contribute to multiple stages of lesion formation and disease progression in atherosclerosis. 9, 15 However, analogous roles in normal heart valves and MVD have not been determined previously.
In the current study, we sought to determine leukocyte subtypes and localization during postnatal heart valve development and also to evaluate macrophage subsets in Axin2 KO mice that exhibit myxomatous valve characteristics. 7 Our analyses revealed that most leukocytes present in normal heart valves are macrophages and dendritic cells that do not differentiate into endothelial cells or VICs. Macrophage subsets are differentially localized in heart valve leaflets, and the increased number of CCR2+ (C-C chemokine receptor type 2) monocytes and CD (cluster of differentiation) 206+ macrophages in murine myxomatous disease supports a role for infiltrating cells in tissue remodeling in diseased heart valves. Similar ECM abnormalities and increased numbers of macrophages were observed in human MVD tissue samples.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Leukocytes Are Present in Heart Valves After Birth
Previous studies have reported that leukocytes are present in adult mouse heart valves as indicated by CD45 expression. 3, 4 Here, the presence of leukocytes in developing heart valves was examined by immunostaining for CD45 in neonatal and young adult heart valves at postnatal day 1 (P1), P7, P30, and P60. At birth, leukocytes represent ≈5% of heart valve cells in aortic valve (AoV) and mitral valve (MV) leaflets ( Figure 1A and 1E) . By 60 days, leukocyte numbers are increased to ≈12% and 17% of cells in AoV and MV, respectively ( Figure 1D , 1H, and 1I). Interestingly, the largest increase is observed between P7 and P30 when numbers of leukocytes double ( Figure 1I ). To determine whether cell proliferation accounted for the observed increase in leukocytes, phospho-histone H3 staining was performed. Although some phospho-histone H3-positive cells (green) are detected in P1 ( Figure 1E ) and P7 heart valves ( Figure 1B) , phospho-histone H3 reactivity was not detected in CD45+ cells (red). At later stages, cell proliferation is rarely observed in juvenile (P30; Figure 1C and 1G) and young adult heart valves (P60; Figure 1D and 1H). Notably, phospho-histone H3 expression is not detected in CD45+ leukocytes at any stage. Together, these data indicate a postnatal increase of leukocytes in AoV and MV leaflets, which is not the result of leukocyte proliferation.
In neonates and juveniles, CD45+ leukocytes are localized in 2 distinct parts of heart valve leaflets, similar to adult heart valves. One of the leukocyte populations is present subjacent to endothelial cells on the ventricularis side of the AoV commissure and similarly on the atrialis of the MV, adjacent to blood flow. The other concentration of leukocytes is located in the distal tip of AoV and MV leaflets ( Figure 1D and 1H) . It is possible that these locations of enhanced biomechanical stress may be more amenable to leukocyte infiltration during the cardiac cycle.
Leukocytes Do Not Contribute to Endothelial and VIC Lineages
Heart valve leaflets are composed primarily of VICs surrounded by a layer of endothelial cells, and previous reports implicate hematopoietic-derived cells as a source of VICs. 3, 4 To investigate whether CD45+ cells contribute to endothelial or interstitial cell populations in the heart valves, CD45-expressing cells were irreversibly labeled for cell lineage studies using CD45Cre;R26tdTomato reporter mice. Endogenous expression of CD45 was compared with CD45Cre-mediated tdTomato expression to determine whether CD45+ lineage cells differentiate into CD45-negative valve interstitial or endothelial cells (Figure 2A ). Completely overlapping expression of tdTomato staining ( Figure 2A and 2A") with CD45 immunostaining (Figure 2A') indicates that hematopoietic-derived cells maintain CD45 expression in juvenile heart valve leaflets. Although closely apposed to endothelial cells, CD45+ cells do not express CD31 and are not located in the endothelium ( Figure 2B ). Flow cytometric analyses further confirmed that leukocytes (CD45+) and endothelial (CD31+) cells are distinct populations in juvenile (1 month) and adult (9 months) pooled AoV and MV leaflets ( Figure 2C ). Only a minimal (0.06%) percentage of cells express both CD45 and CD31, and this number was not significantly changed with age ( Figure 2C ). Thus, CD45+ lineage cells maintain CD45 expression in mature valve leaflets and do not contribute to significant numbers of valve endothelial cells.
CD45+ cells are localized in the valve interstitium, predominantly at the distal tips of developing AoV and MV. To determine whether CD45+ cells exhibit ECM expression characteristic of VICs as reported previously, 3 cells from dissociated AoV and MV leaflets from 1-month-old mice were subjected to FACS (fluorescence-activated cell sorting) to separate leukocytes (CD45+ cells) and VICs (CD45− and CD31− cells). Sorted CD45+ and CD45−;CD31− cell populations were analyzed for expression of genes encoding major ECM components of the heart valves, including Postn (periostin), Col1a1 and Col3a1 (collagen type 1a1 and type 3a1), and Vcan (versican), as well as sox9, which encodes a VIC transcription factor, by qPCR (quantitative polymerase chain reaction). As expected, robust expression of VIC markers was detected in CD45−;CD31− cells ( Figure 2D ). In contrast, CD45+ leukocytes express extremely low levels of Col3a1, and all other VIC genes are barely expressed in leukocytes. Absence of vimentin staining in CD45+ lineage cells ( Figure 2E ) demonstrates further that leukocytes do not exhibit VIC properties. Lineage tracing of PostnCre expressing cells confirmed that CD45 is not expressed in Postn lineage cells in juvenile heart valve leaflets ( Figure 2F ). Finally, flow cytometric analyses reaffirmed that Postn-expressing cells (GFP+ [green fluorescent protein]) are distinct from leukocytes in 1-and 9-monthold heart valve leaflets. Indeed, only 0.7±0.6% of CD45+ cells express Postn-a percentage that is not significantly increased with age ( Figure 2G ). Thus, leukocyte lineages are distinct from heart valve endothelial or interstitial cell populations during heart valve homeostasis.
Heart Valve Leukocytes Are Predominantly Macrophages and Dendritic Cells
Because CD45 is a pan-leukocyte marker, we used additional lineage markers to characterize which immune cell types are present in heart valves. The majority of leukocytes within the ventricles and conduction system atrioventricular node of mouse hearts express C-X3-C motif Cx3cr1 (chemokine receptor 1)-an indicator of myeloid-derived lineages. 8, 16 Similarly, on examination of juvenile pooled AoV and MV leaflets from Cx3Cr1Cre;R26 mTmG mice, the vast majority of CD45+ leukocytes (84.7±2.2%) were GFP positive, indicative of Cx3Cr1-expressing origin ( Figure 3A) . Moreover, >99% of the GFP-positive cells sorted from Cx3Cr1Cre;R26 mTmG valve leaflets express CD11b, indicative of myeloid lineage identity ( Figure 3B' and 3B") .
Because dendritic cells have been observed in heart valves, 17 cells from P30 valve leaflets were sorted to further delineate myeloid subsets ( Figure 3C ). First, live single cells were gated for CD45 and CD11b ( Figure I in the online-only Data Supplement) to distinguish myeloid ( Figure 3C , gate R1) from nonmyeloid cells ( Figure 3C , gate R2). Within the nonmyeloid CD11b− compartment, dendritic cells account for >50% of the cells ( Figure 3C , gate R2), whereas the remainder contribute to other immune cell populations, such as lymphocytes. Among CD11b+ myeloid cells, only 10.2±2.7% were dendritic cells (CD11c+; F4/80−; Figure 3C , gate R1). The remainder consisted of macrophages (F4/80+, CD11c+), further supported by the presence of CD64+ cells by immunohistochemistry ( Figure 3D ). Thus, myeloid lineage cells in P30 valves consist of both macrophages (>60% of CD45+ cells) and dendritic cells (≈20% of CD45+ for both myeloid and nonmyeloid dendritic cells).
Flow cytometric analysis was performed on living singlet cell preparations gated on CD45 and CD11b ( Figure I in the online-only Data Supplement) to evaluate the macrophage cell types in pooled P7, P30, or P60 AoV and MV leaflets. At all stages, ≈80% of leukocytes were labeled with CD11b, among which 80% were double positive for macrophage markers, CD11b, and F4/80 ( Figure 3E and 3F) , which is comparable with immunostaining. Interestingly, the percentage of macrophages (CD45+, CD11b+, and F4/80+) present in heart valves was similar from P7 to P60 ( Figure 3F ). However, the percentage of recruited macrophages (F4/80+ and CCR2+) was significantly increased between P7 and P30 ( Figure 3E and 3F)-the period with the highest increase of leukocyte number in heart valves ( Figure 1I ). The F4/80+ macrophage population is heterogeneous, composed predominantly of CD206+ cells at P7 and an MHCII+ (major histocompatibility complex II) population that increases with age ( Figure 3E and 3F). The age-dependent differences in macrophage cell types were confirmed by immunohistochemistry, whereby both the AoV and MV exhibited a switch from a predominant CD206+ macrophage population at P7 to a more heterogeneous population at P30, consisting of both CD206+ and MHCII+ subtypes ( Figure 3G through 3L) . MV leaflets also exhibited a higher percentage of CD206+ macrophages than that of AoV ( Figure 3M ). Interestingly, these 2 macrophage subtypes display specific localization in AoV, with CD206+ cells located on the flow side, whereas MHCII+ cells are mostly found in the tip of adult P60 AoV leaflet ( Figure 3I and 3L) . Although other minor immune cell populations, such as lymphocytes and neutrophils, remain to be characterized, macrophages and dendritic cells account for most of the leukocytes found in heart valve leaflets.
Proinflammatory ECM and Macrophage Numbers Are Increased in Mouse and Human Myxomatous Heart Valves
Myxomatous heart valve disease is characterized by increased deposition of glycosaminoglycans, namely hyaluronan, in addition to increased numbers of leukocytes and macrophages in humans 2 and mice. 6, 7 In inflammatory disease, hyaluronan is bound covalently by the heavy chain (HC) of IαI (inter-α-trypsin inhibitor) giving rise to the HC-hyaluronan complex, which functions to attract and sequester immune cells.
18 Axin2 KO mice display thickened heart valves with increased leukocytes 7 and no evidence of cell death by TUNEL (terminal deoxynucleotide transferase dUTP nick-end labeling; Figure 4A and 4B). IαI staining and CD45+ cells are colocalized on the flow side of Axin2 wild-type (WT) leaflets ( Figure 4C) , and both are expanded in myxomatous AoV leaflets from Axin2 KO mice ( Figure 4D, arrowheads) . The ratio of IαI to hyaluronan area is increased in Axin2 KO valves ( Figure 4E, 4F, and 4G) , confirming quantitatively that HChyaluronan complexes are increased in myxomatous leaflets.
Although there is accumulating evidence that human myxomatous MVs exhibit increased CD45 leukocytes, 2 specific leukocyte lineages and potential factors promoting immune cell infiltration in diseased valves are not known. The presence of proinflammatory ECM remodeling and macrophages was examined in human myxomatous and control MVs harvested and processed as described previously. 19 In myxomatous valves, characteristic loss of trilaminar organization and increased deposition of glycosaminoglycans interspersed with fibrillar collagen were apparent in comparison with control valve tissue as detected by Movat pentachrome staining ( Figure 5A and 5B). Relative to controls, proteoglycan expression, indicated by HABP (hyaluronic acid-binding protein), is increased with MVD, as is IαI indicative of modified immunogenic ECM (Figure 5A' , 5B', and 5C). Likewise, macrophages, as defined by CD64, 20 also are significantly increased in human MVD and are localized to regions of proinflammatory ECM remodeling (Figure 5A", 5B", and 5D ). The colocalization of increased macrophages with increased HABP and IαI expression in human MVD supports a common mechanism of myxomatous degeneration in mouse models, such as Axin2 KO mice, and human valve disease.
Identification of Macrophage Subsets in Axin2 KO Mouse Myxomatous Heart Valves
Infiltrating macrophages are predominant in sterile injury response in atherosclerosis and heart failure, 9 and chemokine expression is induced at early stages of MVD in Axin2 KO mice. 7 The presence of macrophages expressing the CCR2 monocyte surface receptor was evaluated as an indicator of myeloid cell infiltration in response to chemokine expression during MVD. 21 Flow cytometric analyses of single live macrophages (CD45+, CD11b+, and F4/80+) isolated from P30 Axin2 WT and KO pooled AoV/MV leaflets ( Figure 6A ) indicate a significant increase of macrophages with proinflammatory markers (CD45+, CD11b+, F4/80+, and CCR2+) in myxomatous AoV/MV leaflets ( Figure 6B) . Interestingly, the CD206+;MHCII− macrophage subset also is significantly increased in myxomatous valves, whereas the CD206−;MHCII+ macrophage subset is not changed (Figure 6A and 6B) . Moreover, a third smaller CD206+;MHCII+ macrophage subset present in WT leaflets also is significantly increased in myxomatous Axin2 KO leaflets ( Figure 6B ). Immunostaining confirms the increased numbers of CD206+ and CD206+;MHCII+ double-positive cells ( Figure 6C and 6D) on the flow side of the AoV leaflets ( Figure 6D, arrowhead) , where HC-hyaluronan complexes also are localized ( Figure 4D ). Altogether, these data indicate an increase of infiltrating CCR2+ monocytes and expansion of CD206+ macrophage subsets in regions of immunogenic ECM remodeling in myxomatous valve leaflets.
Discussion
Here, we show that leukocytes are present in murine heart valves and that their numbers increase during the first weeks after birth when valve leaflets undergo physiological ECM remodeling. These leukocytes are mostly nonmyeloid dendritic cells (CD11b− and CD11c+) and myeloid cells (CD11b+) composed of 2 major macrophage (F4/80+) subsets expressing CD206+ or MHCII+, and a small population of myeloid dendritic cells. Between P7 and P30, CCR2+ macrophages are significantly increased, indicating leukocyte infiltration of valves after birth. During heart valve homeostasis, leukocytes do not express major VIC ECM protein genes and are distinct from endothelial cells. In MVD in mice and humans, increased numbers of macrophages are present in regions of proteoglycan enrichment and immunogenic hyaluronan remodeling. Moreover, infiltrating CCR2+ monocyte numbers increase, along with expansion of CD206+ macrophage subsets in myxomatous valves of Axin2 KO mice. Together, these studies demonstrate alterations in macrophage lineage heterogeneity in heart valve development and myxomatous disease. Future studies are needed to determine potential roles for tissue-resident and infiltrating macrophages in normal valve remodeling and homeostasis, as well as specific contributions to MVD progression.
The presence of CD206+ macrophages in heart valves at birth until at least P7 is consistent with tissue-resident macrophages derived from embryonic progenitors originating in the yolk sac or fetal liver. 22 Between P7 and P30, when definitive hematopoiesis is established, macrophage subtypes shift most dramatically with a rise and differentiation of a CD206−;MHCII+ macrophage subset. This is accompanied by a decreased proportion of resident macrophages (CD206+ and MHCII−), similar to macrophage transitions in the developing myocardium. 10 At the same time, heart valves undergo elongation and ECM remodeling, leading to maturation of trilaminar leaflets in the month after birth. Interestingly, leukocyte subpopulations are localized at the valve leaflet commissures and distal tips, regions of enhanced biomechanical stress, which could lead to adhesion and differentiation of macrophages. 23 Targeted manipulation of monocyte and macrophage subpopulations is needed to definitively determine whether these infiltrating cells contribute to heart valve maturation after birth.
Although their functions in adult heart valve homeostasis are not known, it has been proposed that circulating bone marrow-derived CD45+ cells contribute to VICs or valve endothelial cells. 3, 4 Here, we show that leukocytes in adult heart valves maintain CD45+ expression and do not express VIC marker genes or the fibroblast proteins, vimentin and periostin. Moreover, leukocytes do not appreciably overlap with PostnCre lineage cells or CD31+ cells (<1%). These data are in contrast to previous reports of infiltrating bone marrowderived cells contributing to resident VICs, based primarily on cell morphology and expression of ECM proteins. 4 The CD45+ hematopoietic cells, including multiple macrophage subtypes, are in close proximity to valve endothelial and interstitial cells, but their specific functions in ECM remodeling, repair, and homeostasis throughout life remain to be elucidated.
In MVD, progressive leaflet thickening and ECM dysregulation lead to long-term compromised function requiring surgical replacement or repair. 24 Damaged endothelial cells 25 and increased expression of interleukins and chemokines, as detected in Axin2 KO mice 7 and human myxomatous MVs, 5 most likely attract and promote infiltration of monocytes in diseased heart valves. In addition, hyaluronan accumulation and HC-hyaluronan complex formation may also attract leukocytes and are proinflammatory. The transfer of HCs from IαI to hyaluronan is catalyzed by Tnfaip6 (tumor necrosis factor-α induced protein 6), 18 which is overexpressed in human myxomatous MVs 5 and in calcified AoVs, 26 further supporting a potential role in macrophage recruitment. An active role for immune cells in human MVD is suspected because macrophages are increased in regions of IαI expression in both mouse and human MVD. In addition, the increased numbers of CD206-expressing macrophages detected in mouse MVD could have a role in promoting tissue repair and regeneration, as has been demonstrated in liver 27 and heart. 10, 11 Together, our studies demonstrate the heterogeneity and lineage diversity transitions of macrophages in heart valves during development and disease. Additional research is needed to determine the specific contributions of macrophage subsets to heart valve homeostasis and remodeling and to determine whether they are positive or negative targets for development of new therapeutic approaches in treatment or management of heart valve disease.
